OhMD APP for Breast Cancer

Memorial Sloan Kettering Cancer Center, New York, NY
Breast CancerOhMD APP - Other
What conditions do you have?

Study Summary

This trial is testing whether text reminders can help people remember to take their cancer medication.

Eligible Conditions
  • Breast Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Up to 1 year

Up to 1 year
Accuracy rate of medication self-administration

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Standard of Care + Intervention
1 of 2

Active Control

Experimental Treatment

45 Total Participants · 2 Treatment Groups

Primary Treatment: OhMD APP · No Placebo Group · N/A

Standard of Care + Intervention
Experimental Group · 1 Intervention: OhMD APP · Intervention Types: Other
Standard of Care
ActiveComparator Group · 1 Intervention: Paper Drug Diary · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 year

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,864 Previous Clinical Trials
591,587 Total Patients Enrolled
194 Trials studying Breast Cancer
94,073 Patients Enrolled for Breast Cancer
Margaret Barton-Burke, PhD, RNPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Eligibility Criteria

Age 18+ · Female Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are going to start taking palbociclib (Ibrance) for the first time, either alone or with other medications like Lstrozole (Femara) or Fulvestrant (Faslodex).
You are able and willing to use a phone app that sends and receives text messages.

Frequently Asked Questions

In what regions can participants access this research trial?

"As of now, there are 7 clinical trial sites open for recruitment. These include Memorial Sloan Kettering Nassau (Limited Protocol Activities) in Rockville Centre, Memorial Sloan Kettering Commack (Limited Protocol Activities) in Commack, and Memorial Sloan Kettering Monmouth (Limited Protocol Activities) in Middletown. There is also a selection of other medical centres accepting patients." - Anonymous Online Contributor

Unverified Answer

How many participants are engaged in this clinical investigation?

"Absolutely. According to the information provided on clinicaltrials.gov, this research program was first advertised in December of 2019 and has since been updated in July 2022. Currently, 100 participants are sought from seven distinct medical centres." - Anonymous Online Contributor

Unverified Answer

Is the patient enrollment for this experiment still open?

"As evidenced by clinicaltrials.gov, this trial is still seeking participants; it was initially published on December 27th 2019 and last revised on July 28th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.